5 Articles in Immunotherapy suggested by Wafik El-Deiry – OncoDaily
5 Articles in Immunotherapy suggested by Wafik El-Deiry / A. Ari Hakimi, Abhinav Pandey, Akshay J. Patel, Andrew Sangho Lee, Anuj Wali, Attila A. Seyhan,
Related Articles
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK
Nature Communications – Colorectal cancer has been linked to multiple environmental factors, however, the role of diet remains incompletely understood. Here, the authors complete a…
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
Debt or Dying: The High Costs of Cancer Care in America, One Patient’s Perspective | JCO Oncology Practice
View all available purchase options and get full access to this article. The following represents disclosure information provided by the author of this manuscript. All…
Elon Musk Sets His Sights on Toppling Another World Leader
Not satisfied with what he’s done to America, the world’s richest man is now looking to interfere in a European country.
One of those ECGs you need to instantly recognize, which learners may struggle with at first
Emergency cardiac care, cardiology, EKGs, ECGs, electrocardiography, echocardiography, dysrhythmias, arrhythmias, STEMI, NonSTEMI, NSTEMI, cardiology
Did headlines saying to throw out black plastic spatulas get ahead of the science? | CBC News
Headlines warning people to throw out their black plastic kitchen utensils live on, as do social media posts warning of “secret toxins” in your kitchen.…
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Key Points. Epcoritamab, a CD3xCD20 bispecific antibody, plus GemOx yields deep, durable responses in second-line or later ASCT-ineligible R/R DLBCLHigher
The Real Reason People Don’t Trust in Science Has Nothing to Do with Scientists
Propaganda works, is the real upshot of a survey showing lingering post-pandemic distrust of science